These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24317684)

  • 41. Identification of PCAG1 as a novel prostate cancer-associated gene.
    Lai Y; Yu Z; Wang Y; Ye J
    Mol Med Rep; 2013 Mar; 7(3):755-60. PubMed ID: 23292432
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of human telomerase reverse transcriptase, Survivin, DD3 and PCGEM1 messenger RNA in archival prostate carcinoma tissue.
    Bialkowska-Hobrzanska H; Driman DK; Fletcher R; Harry V; Razvi H
    Can J Urol; 2006 Feb; 13(1):2967-74. PubMed ID: 16515751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI.
    Tiacci E; Orvietani PL; Bigerna B; Pucciarini A; Corthals GL; Pettirossi V; Martelli MP; Liso A; Benedetti R; Pacini R; Bolli N; Pileri S; Pulford K; Gambacorta M; Carbone A; Pasquarello C; Scherl A; Robertson H; Sciurpi MT; Alunni-Bistocchi G; Binaglia L; Byrne JA; Falini B
    Blood; 2005 Apr; 105(7):2812-20. PubMed ID: 15576473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma.
    Balleine RL; Fejzo MS; Sathasivam P; Basset P; Clarke CL; Byrne JA
    Genes Chromosomes Cancer; 2000 Sep; 29(1):48-57. PubMed ID: 10918393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dropping in on the lipid droplet- tumor protein D52 (TPD52) as a new regulator and resident protein.
    Chen Y; Frost S; Byrne JA
    Adipocyte; 2016; 5(3):326-32. PubMed ID: 27617178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?
    Byrne JA; Frost S; Chen Y; Bright RK
    Tumour Biol; 2014 Aug; 35(8):7369-82. PubMed ID: 24798974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges.
    Ubanako P; Mirza S; Ruff P; Penny C
    Front Mol Biosci; 2024; 11():1447953. PubMed ID: 39355533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross talk of tumor protein D52 (TPD52) with KLF9, PKCε, and MicroRNA 223 in ovarian cancer.
    Khan K; Zafar S; Badshah Y; Ashraf NM; Rafiq M; Danish L; Shabbir M; Trembley JH; Afsar T; Almajwal A; Razak S
    J Ovarian Res; 2023 Oct; 16(1):202. PubMed ID: 37833790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AMPK targets a proto-oncogene TPD52 (isoform 3) expression and its interaction with LKB1 suppress AMPK-GSK3β signaling axis in prostate cancer.
    Khilar P; Sruthi KK; Parveen SMA; Natani S; Jadav SS; Ummanni R
    J Cell Commun Signal; 2023 Sep; 17(3):957-974. PubMed ID: 37040029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA in adenoid cystic carcinoma (Review).
    Li Y; Gu F; He Y; Xiang J; Huang X; Wang Y; Chen R
    Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36484384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor protein D52 (TPD52) affects cancer cell metabolism by negatively regulating AMPK.
    Chen Y; Peng C; Tan W; Yu J; Zayas J; Peng Y; Lou Z; Pei H; Wang L
    Cancer Med; 2023 Jan; 12(1):488-499. PubMed ID: 35666017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determining KLF14 tertiary structure and diagnostic significance in brain cancer progression.
    Zahra K; Shabbir M; Badshah Y; Trembley JH; Badar Z; Khan K; Afsar T; Almajwal A; Alruwaili NW; Razak S
    Sci Rep; 2022 May; 12(1):8039. PubMed ID: 35577881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52.
    Li Y; Sun Y; Li Z; Li S; Wu C
    J Healthc Eng; 2022; 2022():4033373. PubMed ID: 35222884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting 3D Structure, Cross Talks, and Prognostic Significance of
    Safi S; Badshah Y; Shabbir M; Zahra K; Khan K; Dilshad E; Afsar T; Almajwal A; Alruwaili NW; Al-Disi D; Abulmeaty M; Razak S
    Front Oncol; 2021; 11():797007. PubMed ID: 35047407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain Acetyl-CoA Production and Phosphorylation of Cytoskeletal Proteins Are Targets of CYP46A1 Activity Modulation and Altered Sterol Flux.
    Mast N; Petrov AM; Prendergast E; Bederman I; Pikuleva IA
    Neurotherapeutics; 2021 Jul; 18(3):2040-2060. PubMed ID: 34235635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model.
    Schrörs B; Boegel S; Albrecht C; Bukur T; Bukur V; Holtsträter C; Ritzel C; Manninen K; Tadmor AD; Vormehr M; Sahin U; Löwer M
    Front Oncol; 2020; 10():1195. PubMed ID: 32793490
    [No Abstract]   [Full Text] [Related]  

  • 57. Star-PAP regulates tumor protein D52 through modulating miR-449a/34a in breast cancer.
    Duan A; Kong L; An T; Zhou H; Yu C; Li Y
    Biol Open; 2019 Nov; 8(11):. PubMed ID: 31649118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-107 Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel.
    Wang G; Ma C; Shi X; Guo W; Niu J
    Open Med (Wars); 2019; 14():456-466. PubMed ID: 31206033
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.